Earnings Feed
Start Free
Home/Filings/4/0001127602-20-001407
4//SEC Filing

Roberts Jonathan C 4

Accession 0001127602-20-001407

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 5:31 PM ET

Size

21.5 KB

Accession

0001127602-20-001407

Insider Transaction Report

Form 4
Period: 2020-01-08
CVS HEALTH CorpCVS
Roberts Jonathan C
SVP and CIO
Transactions
  • Exercise/Conversion

    Common Stock

    2020-01-08$54.53/sh+68,844$3,754,063→ 102,607.631 total
  • Exercise/Conversion

    Stock Option

    2020-01-08−68,844→ 0 total
    Exercise: $54.53From: 2014-04-01Exp: 2020-04-01→ Common Stock (68,844 underlying)
  • Sale

    Common Stock

    2020-01-08$72.63/sh−57,563$4,180,801→ 45,044.631 total
Holdings

  • Common Stock (restricted)

    41,246

  • ESOP Common Stock

    (indirect: By ESOP)
    5,772.679

  • Stock Option

    Exercise: $45.93From: 2015-09-04Exp: 2022-09-04→ Common Stock (108,870 underlying)
    108,870

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (161,318 underlying)
    161,318

  • Stock Unit

    230,362.662

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (68,482 underlying)
    68,482

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (200,358 underlying)
    200,358

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (303,010 underlying)
    303,010

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (1,424.149 underlying)
    1,424.149

  • Stock Option

    Exercise: $74.29From: 2015-04-01Exp: 2021-04-01→ Common Stock (73,433 underlying)
    73,433

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (248,131 underlying)
    248,131
Footnotes (11)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
  • [F10]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2020.
  • [F2]Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $71.75 and 73.04 per share.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2014.
  • [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2015.
  • [F6]Option became exercisable in three equal annual installments, commencing 9/4/2015.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/3/2018.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001410515

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:31 PM ET
Size
21.5 KB
View on SEC.gov